dapsone has been researched along with Anemia in 22 studies
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemoglobin concentration (Hb) was measured at 6 week intervals for up to a year in 84 patients with rheumatoid arthritis treated with dapsone." | 7.67 | Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin. ( Grindulis, KA; McConkey, B, 1984) |
| "Between March 2004 and March 2008, in an area of western Kenya with year round malaria transmission with high seasonal intensity and high usage of insecticide-treated nets, we conducted a randomized, double-blind placebo-controlled trial with SP plus 3 days of artesunate (SP-AS3), 3 days of amodiaquine-artesunate (AQ3-AS3), or 3 days of short-acting chlorproguanil-dapsone (CD3) administered at routine expanded programme of immunization visits (10 weeks, 14 weeks and 9 months)." | 5.14 | Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. ( Hamel, MJ; Kariuki, S; Lindblade, K; Newman, RD; Odhiambo, FO; Otieno, P; Peterson, E; Slutsker, L; ter Kuile, FO; Vulule, J; Williamson, J, 2010) |
| "Changes in hemoglobin (HGB) and serum albumin (SA) concentration associated with the onset of symptomatic erythema nodosum leprosum (ENL) were studied by comparing the values obtained on the day thalidomide or prednisone therapy commenced, with each patients' preceding values." | 3.71 | Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy. ( Rea, TH, 2001) |
| "Hemoglobin concentration (Hb) was measured at 6 week intervals for up to a year in 84 patients with rheumatoid arthritis treated with dapsone." | 3.67 | Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin. ( Grindulis, KA; McConkey, B, 1984) |
| "The Clinical Trial for Uniform Multidrug Therapy for Leprosy Patients in Brazil (U-MDT/CT-BR), designed to evaluate the effectiveness of a six-months regimen, assessed the adverse effects caused by the drugs." | 2.87 | Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach. ( Bührer-Sékula, S; Cruz, RCDS; Gonçalves, HS; Moraes, MEA; Penna, GO; Penna, MLF; Pontes, MAA; Stefani, MMA; Talhari, S, 2018) |
| "Acute myeloid leukemia was the most common malignancy (in 24 of 83 patients [29%])." | 1.48 | Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center. ( Ashchyan, HJ; Gowda, A; James, WD; McMahon, CM; Micheletti, RG; Nelson, CA; Noe, MH; Perl, AE; Rosenbach, M; Wu, B, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ogino, T | 1 |
| Tsuji, K | 1 |
| Tojo, T | 1 |
| Igari, N | 1 |
| Seki, N | 1 |
| Sudo, Y | 1 |
| Manda, T | 1 |
| Nishigaki, F | 1 |
| Matsuo, M | 1 |
| Bailey, NJ | 1 |
| Kraft, RM | 1 |
| Schouten, WM | 1 |
| Nelson, CA | 1 |
| Noe, MH | 1 |
| McMahon, CM | 1 |
| Gowda, A | 1 |
| Wu, B | 1 |
| Ashchyan, HJ | 1 |
| Perl, AE | 1 |
| James, WD | 1 |
| Micheletti, RG | 1 |
| Rosenbach, M | 1 |
| Cruz, RCDS | 1 |
| Bührer-Sékula, S | 1 |
| Penna, GO | 1 |
| Moraes, MEA | 1 |
| Gonçalves, HS | 1 |
| Stefani, MMA | 1 |
| Penna, MLF | 1 |
| Pontes, MAA | 1 |
| Talhari, S | 1 |
| Ordieres Ortega, L | 1 |
| Temiño Frade, C | 1 |
| Demelo-Rodríguez, P | 1 |
| Odhiambo, FO | 1 |
| Hamel, MJ | 1 |
| Williamson, J | 1 |
| Lindblade, K | 1 |
| ter Kuile, FO | 1 |
| Peterson, E | 1 |
| Otieno, P | 1 |
| Kariuki, S | 1 |
| Vulule, J | 1 |
| Slutsker, L | 1 |
| Newman, RD | 1 |
| SMITH, RS | 1 |
| ALEXANDER, S | 1 |
| HOLLAND, PD | 1 |
| VIANI, H | 1 |
| GISSLEN, H | 1 |
| HERSLE, K | 1 |
| RAMANUJAM, K | 1 |
| SMITH, M | 1 |
| Aponte, JJ | 1 |
| Menendez, C | 1 |
| Schellenberg, D | 1 |
| Kahigwa, E | 1 |
| Mshinda, H | 1 |
| Vountasou, P | 1 |
| Tanner, M | 1 |
| Alonso, PL | 1 |
| Puavilai, S | 1 |
| Chutha, S | 1 |
| Polnikorn, N | 1 |
| Timpatanapong, P | 1 |
| Tasanapradit, P | 1 |
| Charuwichitratana, S | 1 |
| Boonthanom, A | 1 |
| Wongwaisayawan, H | 1 |
| Grindulis, KA | 1 |
| McConkey, B | 1 |
| Woodruff, AW | 1 |
| Woodbury, GR | 1 |
| Fried, W | 1 |
| Ertle, JO | 1 |
| Malkinson, FD | 1 |
| Freund, YR | 1 |
| Dousman, L | 1 |
| Riccio, ES | 1 |
| Sato, B | 1 |
| MacGregor, JT | 1 |
| Mohagheghpour, N | 1 |
| Rea, TH | 1 |
| Rosove, MH | 1 |
| Harwig, SS | 1 |
| Ahmed, RA | 1 |
| Connor, B | 1 |
| Bairrington, JD | 1 |
| Sulkowski, TS | 1 |
| Merritt, JH | 1 |
| Bernardini, AT | 1 |
| Sharma, DR | 1 |
| Dhar, DC | 1 |
| Mukherji, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya[NCT00111163] | 1,516 participants | Interventional | 2004-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dapsone and Anemia
| Article | Year |
|---|---|
Recent work concerning anemia in the tropics.
Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Presch | 1982 |
3 trials available for dapsone and Anemia
| Article | Year |
|---|---|
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Topics: Adolescent; Adult; Anemia; Brazil; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; H | 2018 |
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Dapsone; Double-Blind Method; Drug Combinations; Hu | 2010 |
Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation.
Topics: Age Factors; Anemia; Animals; Antigens, Protozoan; Child, Preschool; Dapsone; Drug Therapy, Combinat | 2007 |
18 other studies available for dapsone and Anemia
| Article | Year |
|---|---|
Discovery of FR115092: a novel antinephritic agent.
Topics: Anemia; Animals; Disease Models, Animal; Male; Mice; Nephritis; Pyridines; Thiazoles | 1998 |
27-Year-Old Woman With Fever, Headache, and Anemia.
Topics: Adult; Anemia; Anti-Infective Agents; Blood Gas Analysis; Dapsone; Female; Fever; Headache; Humans; | 2020 |
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
Topics: Academic Medical Centers; Adrenal Cortex Hormones; Adult; Aged; Anemia; Arthralgia; Colchicine; Daps | 2018 |
Late onset dapsone hypersensitivity syndrome.
Topics: Aged, 80 and over; Anemia; Dapsone; Drug Hypersensitivity Syndrome; Erythema Multiforme; Erythrocyte | 2019 |
Heinz-body anaemia due to dapsone.
Topics: Anemia; Anemia, Hemolytic; Dapsone; Hemoglobinopathies; Humans; Sulfones | 1959 |
THE CONTROL OF DAPSONE HEINZ-BODY ANAEMIA WITH ADRENAL CORTICOSTEROIDS.
Topics: Adrenal Cortex Hormones; Anemia; Child; Dapsone; Dermatitis Herpetiformis; Hemoglobinometry; Humans; | 1964 |
LABORATORY INVESTIGATIONS IN SULPHONE-INDUCED HAEMOLYTIC ANAEMIA.
Topics: Anemia; Anemia, Hemolytic; Bilirubin; Biomedical Research; Dapsone; Erythrocytes; Haptoglobins; Hein | 1964 |
Haemolytic anaemia during treatment of leprosy with diaminodiphenylsulphone by mouth.
Topics: Anemia; Anemia, Hemolytic; Dapsone; Humans; Leprosy; Mouth; Sulfones | 1951 |
Incidence of anemia in leprosy patients treated with dapsone.
Topics: Adolescent; Adult; Aged; Anemia; Dapsone; Female; Humans; Leprosy; Male; Middle Aged | 1984 |
Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin.
Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Dapsone; Female; Hemoglobins; Humans; Male; Middle Aged; | 1984 |
Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis.
Topics: Agranulocytosis; Anemia; Dapsone; Female; Humans; Middle Aged; Vasculitis, Leukocytoclastic, Cutaneo | 1993 |
Immunohematotoxicity studies with combinations of dapsone and zidovudine.
Topics: AIDS-Related Opportunistic Infections; Anemia; Animals; Anti-HIV Agents; Antiprotozoal Agents; Bone | 2001 |
Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
Topics: Anemia; Dapsone; Erythema Nodosum; Hemoglobins; Humans; Leprostatic Agents; Leprosy, Lepromatous; Pr | 2001 |
Dapsone and Heinz bodies.
Topics: Anemia; Dapsone; Erythrocyte Count; Heinz Bodies; Humans; Methemoglobinemia | 1985 |
Case for diagnosis: leukocytoclastic vasculitis.
Topics: Anemia; Arteritis; Blood Sedimentation; Body Weight; Dapsone; Diagnosis, Differential; Humans; Leuko | 1973 |
Reduced pressure potentiation of the side effects of the antimalarial, Dapsone.
Topics: Aerospace Medicine; Altitude; Anemia; Animals; Asia, Southeastern; Dapsone; Erythrocyte Count; Hyper | 1967 |
Diamino diphenyl sulfone in leprosy chemoprophylaxis.
Topics: Adolescent; Anemia; Child; Child, Preschool; Dapsone; Evaluation Studies as Topic; Humans; Infant; L | 1971 |
Anaemia in subacute toxicity with DDS in white rats.
Topics: Anemia; Animals; Dapsone; Male; Rats | 1969 |